Currently, NLM is not updating the Disaster Information Management Research Center (DIMRC) website, and is limiting updates to the Disaster Lit database to COVID-19 related data collection tools found in the DR2.
We are no longer adding links to other new disaster-related information. The content of select resources from Disaster Lit will be digitized and made available through Digital Collections and Bookshelf.
Annotation:An international population cohort to investigate genetic susceptibility to the novelcoronavirus (COVID-19). This study seeks to recruit new participants from the general population during the COVID-19 pandemic into a large genetic epidemiological cohort. Recruitment (and subsequent saliva sampling and antibody testing) will take place remotely. Coronagenes re-purposes much of the infrastructure and expertise from the VIKING II study. This launched in January 2020 and paused in March 2020 due to the pandemic, with over 4,000 participants registered. In Coronagenes, data will be collected at baseline through an online questionnaire and longitudinally for UK participants through linkage to routine NHS data (and where possible other healthcare system data) in electronic health records (EHR).
Annotation:An international population cohort to investigate genetic susceptibility to the novelcoronavirus (COVID-19). This study seeks to recruit new participants from the general population during the COVID-19 pandemic into a large genetic epidemiological cohort. Recruitment (and subsequent saliva sampling and antibody testing) will take place remotely. Coronagenes re-purposes much of the infrastructure and expertise from the VIKING II study. This launched in January 2020 and paused in March 2020 due to the pandemic, with over 4,000 participants registered. In Coronagenes, data will be collected at baseline through an online questionnaire and longitudinally for UK participants through linkage to routine NHS data (and where possible other healthcare system data) in electronic health records (EHR).
Population: All/anyone
Length: 50 questions
Language(s): English
Annotation:This tool, updated on October 23, 2020, has been designed to assess the capacity of laboratories that have implemented or intend to implement testing for SARS-CoV-2, the virus that causes novelcoronavirus disease 2019 (COVID-19). The tool is a shortened version of the 2012 laboratory assessment tool that is widely used to assess national laboratory systems and the capacity of laboratories....[See more] [See less]
Annotation:This web page details how the COVID-19 pandemic has underscored the need to continue to integrate emotional and behavioral health as part of standard care, and how pediatricians, professionals, families, and agencies can partner together to support the emotional and behavioral health of the nation’s children, adolescents, and families during this public health crisis....[See more] [See less]
Annotation:The aim of the strategies provided within this guidance is to reduce risk of COVID-19 exposure and spread of infection to staff, children, and families involved with early care and education programs. The guidance also explores primary prevention such as immunizations, well child care, and special considerations for children with special health care needs....[See more] [See less]
Annotation:With a new infectious disease threat at hand, scientists at the NIH swiftly developed a vaccine candidate against the novelcoronavirus that causes COVID-19. The pre-clinical effort for a fast, reliable, and universal vaccine was driven in part by the speaker in this one-hour presentation....[See more] [See less]
Annotation:This web page, updated on October 12, 2020, provides answers to frequently asked questions during the COVID-19 pandemic about family presence policies, which are are critical components of family-centered care for all children and are particularly important for children with special health care needs, including those with disabilities, medical complexity, and serious illness....[See more] [See less]
Annotation:This web page, updated on October 9, 2020, describes how to order the CDC 2019 NovelCoronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel and supplies. In addition to this test, CDC has developed a diagnostic test that can be used to detect SARS-CoV-2, influenza A, and influenza B viruses at the same time. This test is called the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay....[See more] [See less]
Annotation:This web page provides interim guidance on the use of rapid antigen detection tests (RADT) for SARS-CoV-2 in the context of the public health system. These guidelines were developed in collaboration with provincial and territorial public health authorities and will be updated periodically as the science evolves....[See more] [See less]
Annotation:The American Academy of Pediatrics (AAP) strongly supports the continued provision of health care for children during the COVID-19 pandemic unless community circumstances related to the pandemic require necessary adjustments. This page, updated on October 6, 2020, provides guidance on several types of screening during the pandemic....[See more] [See less]